Pediatric Obesity and GLP-1 Agonists Are We Ready for Pharmacologic Therapy in Children Review Abstract Pediatric obesity has emerged as one of the most important public health challenges of the twenty-first century. Once viewed primarily as a consequence of lifestyle choices, obesity is now widely recognized
Author: Nancy Ogbonna
Perimenopause vs Thyroid vs Mood: Sorting Symptom Overlap Efficiently
Perimenopause vs Thyroid vs Mood Sorting Symptom Overlap Efficiently Review Abstract Perimenopause, thyroid dysfunction, depression, and anxiety represent some of the most common and diagnostically challenging conditions encountered in midlife clinical practice. These disorders frequently coexist and share a broad range of overlapping symptoms, creating major complexity
Point-of-Care Gastric Ultrasound: Should It Become the New “NPO Check”?
Point-of-Care Gastric Ultrasound Should It Become the New “NPO Check” Review Abstract Point of care gastric ultrasound has emerged as an important bedside imaging modality that enables clinicians to assess gastric contents in real time before anesthesia, procedural sedation, or urgent interventions. By providing direct visualization
REBOA in Non-Trauma Cardiac Arrest: Heroic Rescue or Futile Effort?
REBOA in Non-Trauma Cardiac Arrest Heroic Rescue or Futile Effort Review Abstract Resuscitative endovascular balloon occlusion of the aorta (REBOA) has emerged as a novel endovascular intervention with potential applications beyond its established role in traumatic hemorrhagic shock. In recent years, interest has grown in
Closed-Incision Negative Pressure Wound Therapy: Which Patients Truly Benefit?
Closed-Incision Negative Pressure Wound Therapy Which Patients Truly Benefit Review Abstract Closed-incision negative pressure wound therapy (ciNPWT), also known as incisional negative pressure wound therapy or prophylactic negative pressure wound therapy, has emerged as an important adjunctive strategy for reducing postoperative wound complications in selected surgical patients.
Coronary Artery Calcium Scoring in 2026: Still Powerful, but Only When Used for the Right Patient
Coronary Artery Calcium Scoring in 2026: Still Powerful, but Only When Used for the Right Patient Review Key Takeaways Coronary artery calcium (CAC) scoring continues to occupy an important role in contemporary cardiovascular risk assessment and remains far from obsolete. Although advances in cardiovascular imaging, biomarker testing, and
GLP-1 Receptor Agonists and Aspiration Risk: From Universal Holding to Risk-Based Perioperative Management
GLP-1 Receptor Agonists and Aspiration Risk: From Universal Holding to Risk-Based Perioperative Management Review Abstract Purpose The rapid adoption of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists has transformed the management of type 2 diabetes mellitus and obesity. As the use
Lecanemab in Real-World Practice: What Early Alzheimer’s Patients Are Actually Experiencing
Lecanemab in Real-World Practice: What Early Alzheimer’s Patients Are Actually Experiencing Review Abstract Lecanemab represents a major milestone in the treatment of Alzheimer’s disease as the first anti amyloid monoclonal antibody to receive traditional approval from the United States Food and Drug Administration for patients with early
Nail Disorders as Clues to Systemic Disease: Evidence, Limitations, and Diagnostic Value in Clinical Practice
Nail Disorders as Clues to Systemic Disease: Evidence, Limitations, and Diagnostic Value in Clinical Practice Review Abstract The physical examination remains a cornerstone of clinical medicine, yet certain components are frequently overlooked despite their diagnostic value. Among these, examination of the nail unit represents a
Osteoporosis Treatment Sequencing: Where Do the Anabolics Fit In?
Osteoporosis Treatment Sequencing Where Do the Anabolics Fit In Review Abstract Osteoporosis management has undergone a remarkable transformation in recent years, moving away from a uniform antiresorptive-first treatment paradigm toward a more individualized, risk-based approach that prioritizes fracture prevention according to the patient’s absolute risk profile. This evolution
